January 19, 2022
Gilead warns of fake HIV medications
Gilead Sciences was reported as filing a lawsuit against certain suppliers and distributors of selling fake versions of its HIV…
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
December 22, 2021
UAB, Mereo good results in Phase 1b/2 Trial of Alvelestat for hospitalized patients with COVID-19
The University of Alabama at Birmingham (UAB) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced top-line data from a Phase 1b/2 clinical trial evaluating alvelestat, a novel, orally active Neutrophil Elastase (NE) inhibitor in hospitalized COVID-19 Respiratory Disease patients.
December 21, 2021
Pfizer get China approval for antifungal Cresemba
Basilea Pharmaceutica’s license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration (NMPA) in China, for the oral formulation of its antifungal Cresemba® (isavuconazole).
December 13, 2021
Pfizer buys Arena Pharmaceuticals ($6.7 billion)
Pfizer will acquire Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases, Pfizer said in a press release Monday.
December 10, 2021
Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18y and above, across six countries.
December 8, 2021
New finding shows that Pfizer’s Covid-19 vaccine can partially protect from the Omicron variant of the virus
New finding shows that Pfizer’s Covid-19 vaccine can partially protect from the Omicron variant of the virus.
October 12, 2021
Hikma launches Micafungin for Injection
Hikma Pharmaceuticals has announced it launched Micafungin for Injection through its US affiliate, Hikma Pharmaceuticals USA Inc. The company has launched 50mg and 100mg doses.
October 5, 2021
Merck to seek emergency use authorization for Molnupiravir, oral antiviral medicine for COVID-19
The drug maker Merck said it plans to seek emergency use authorization in the U.S. as soon as possible and to submit applications to regulatory agencies worldwide for Molnupiravir, which could be the first oral antiviral medicine for COVID-19.
September 20, 2021
Cellbox Solutions kicks off subsidiary in the USA
Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market.
July 16, 2021
Corvus Pharmaceuticals Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-19 Due to Vaccine Effectiveness in Reducing Hospitalizations
Mupadolimab Phase 1/1b oncology clinical trial continues, with a focus on leveraging B cell activation and enhancement of anti-viral antibodies…